- Patent Title: Composition for treating or preventing metabolic disease, containing, as active ingredient, extracellular vesicles derived from Akkermansia muciniphila bacteria
-
Application No.: US16824111Application Date: 2020-03-19
-
Publication No.: US11291694B2Publication Date: 2022-04-05
- Inventor: Yoon-Keun Kim , Hyun-Taek Park
- Applicant: MD HEALTHCARE INC.
- Applicant Address: KR Seoul
- Assignee: MD HEALTHCARE INC.
- Current Assignee: MD HEALTHCARE INC.
- Current Assignee Address: KR Seoul
- Agency: Vorys, Sater, Seymour & Pease LLP
- Agent Mih Suhn Koh
- Priority: KR10-2014-0060409 20140520,KR10-2015-0068864 20150518
- Main IPC: A61P1/00
- IPC: A61P1/00 ; A61K8/99 ; A61K35/74 ; A23L33/10 ; A23L33/135

Abstract:
The present invention relates to a pharmaceutical and food composition for treating, preventing, or alleviating a metabolic disease, containing, as an active ingredient, extracellular vesicles derived from Akkermansia muciniphila. The composition of the present invention can be used as a pharmaceutical/food composition and the like for treating, preventing, or alleviating metabolic diseases, in particular metabolic diseases such as obesity, diabetes, hyperlipidemia, arteriosclerosis, and hypertension, occurring or exacerbated due to a high fat diet. In addition, in the present invention, a fermented food itself, prepared by adding Akkermansia muciniphila, can be used for the purpose of preventing or alleviating a metabolic disease occurring or exacerbated due to a high fat diet.
Public/Granted literature
Information query